AI assistant
Sending…
Adaptive Biotechnologies Corp — Director's Dealing 2023
Feb 3, 2023
31660_dirs_2023-02-03_1732562f-f3d2-47a6-8b9c-2b9bbb224022.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2023-02-02
Reporting Person: HERSHBERG ROBERT (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-02 | Common Stock | M | 53000 | $0.45 | Acquired | 61193 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-02 | Stock Option (Right to Buy) | $0.45 | M | 53000 | Disposed | 2023-02-04 | Common Stock (53000) | Direct |
Footnotes
F1: The option is fully vested and exercisable.
More from Adaptive Biotechnologies Corp
Annual Report
2026
Apr 24
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 4
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 6
Regulatory Filings
2026
Feb 5
Director's Dealing
2026
Feb 4